News
McKinsey & Co. has agreed to pay $650 million to resolve a Justice Department investigation into the consulting firm’s work ...
McKinsey to pay $650m to settle US opioid consulting probe. Prosecutors say McKinsey provided Purdue advice on measures it could take to ‘turbocharge’ OxyContin sales.
McKinsey in talks to pay over $600 million to resolve DOJ probe Settlement involves dismissal of charges if terms are met McKinsey previously settled lawsuits without admitting liability BOSTON ...
Consulting firm McKinsey & Co is close to an agreement with U.S. prosecutors to pay more than $500 million to resolve longstanding federal investigations into its past work helping opioid makers ...
McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how ...
McKinsey & Company to pay $650 million to settle U.S. opioid consulting probe A former top partner at McKinsey has also agreed to plead guilty to obstruction of justice in the federal probe ...
Exclusive-McKinsey Nears Deferred Prosecution Pact in US Opioid Probe, Sources Say By Nate Raymond and Mike Spector BOSTON (Reuters) - McKinsey & Co is in the final stages of negotiating a ...
McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how to ...
McKinsey & Co. is close to reaching a deal with U.S. prosecutors to settle federal probes into its past work helping opioid makers boost sales Skip to main content Search ...
McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results